A longitudinal assessment of frailty in young adult survivors of childhood cancer

儿童癌症年轻幸存者虚弱的纵向评估

基本信息

项目摘要

DESCRIPTION (provided by applicant): Treatment for children with cancer has progressed over the past four decades so that, today, over 80% of children diagnosed with a malignancy will become long-term survivors. Currently, there are over 350,000 survivors of childhood cancer living in the United States; nearly 250,000 of these individuals are younger than age 40 years. Unfortunately, treatment for childhood cancer continues to require agents designed to destroy malignant cell lines, and normal tissue is not always spared. While early treatment-related organ specific toxicities are not always apparent, many childhood cancer survivors report symptoms that interfere with daily life, including exercise induced shortness of breath, fatigue, and reduce capacity to participate in physical activity. These symptoms may be a hallmark of premature aging, or frailty. Frailty is a phenotype most commonly described in older adults; it indicates persons who are highly vulnerable to adverse health outcomes. Frailty may help explain why nearly two thirds of childhood cancer survivors have at least one severe chronic health condition 30 years from diagnosis, why childhood cancer survivors are more likely than peers to be hospitalized for non-obstetrical reasons, and why they have mortality rates more than eight times higher than age-and-gender matched members of the general population. The aims of this proposal are to enumerate the prevalence of physiologic frailty over time in a group of young adult survivors of childhood cancer, to describe the association between frailty and the development or progression of chronic conditions, and to describe the associations between personal factors, cancer-related treatment modalities, health behaviors, and frailty in this population.
描述(由申请人提供):在过去的四十年中,儿童癌症的治疗取得了进展,因此,今天,超过80%的被诊断为恶性肿瘤的儿童将成为长期幸存者。目前,在美国有超过35万的儿童癌症幸存者;这些人中有近25万人年龄在40岁以下。不幸的是,儿童癌症的治疗仍然需要破坏恶性细胞系的药物,而正常组织并不总是幸免。虽然早期治疗相关的器官特异性毒性并不总是很明显,但许多儿童癌症幸存者报告的症状会干扰日常生活,包括运动引起的呼吸短促、疲劳和参加体育活动的能力下降。这些症状可能是早衰或身体虚弱的标志。虚弱是最常见于老年人的一种表型;它指的是那些非常容易受到不利健康结果影响的人。虚弱可能有助于解释为什么近三分之二的儿童癌症幸存者在确诊后30年内至少患有一种严重的慢性健康状况,为什么儿童癌症幸存者比同龄人更有可能因非产科原因住院,以及为什么他们的死亡率比年龄和性别匹配的一般人群高8倍以上。本提案的目的是列举一组儿童期癌症的年轻成年幸存者中随时间推移的生理虚弱的患病率,描述虚弱与慢性疾病的发展或进展之间的联系,并描述这一人群中个人因素、癌症相关治疗方式、健康行为和虚弱之间的联系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kirsten Kimberlie Ness其他文献

Kirsten Kimberlie Ness的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kirsten Kimberlie Ness', 18)}}的其他基金

Web-based Physical Activity Intervention for Children with ALL
针对 ALL 儿童的基于网络的身体活动干预
  • 批准号:
    9298607
  • 财政年份:
    2016
  • 资助金额:
    $ 53.52万
  • 项目类别:
A longitudinal assessment of frailty in young adult survivors of childhood cancer
儿童癌症年轻幸存者虚弱的纵向评估
  • 批准号:
    8630497
  • 财政年份:
    2014
  • 资助金额:
    $ 53.52万
  • 项目类别:
A longitudinal assessment of frailty in young adult survivors of childhood cancer
儿童癌症年轻幸存者虚弱的纵向评估
  • 批准号:
    8846554
  • 财政年份:
    2014
  • 资助金额:
    $ 53.52万
  • 项目类别:
Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors
振动干预促进儿童癌症幸存者骨质增强
  • 批准号:
    8037771
  • 财政年份:
    2010
  • 资助金额:
    $ 53.52万
  • 项目类别:
Vibration Intervention for Bone Enhancement in Childhood Cancer Survivors
振动干预促进儿童癌症幸存者骨质增强
  • 批准号:
    7788569
  • 财政年份:
    2010
  • 资助金额:
    $ 53.52万
  • 项目类别:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
儿童期急性淋巴细胞白血病成年幸存者的运动能力和体力活动
  • 批准号:
    7795129
  • 财政年份:
    2009
  • 资助金额:
    $ 53.52万
  • 项目类别:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
儿童期急性淋巴细胞白血病成年幸存者的运动能力和体力活动
  • 批准号:
    7656171
  • 财政年份:
    2009
  • 资助金额:
    $ 53.52万
  • 项目类别:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
儿童期急性淋巴细胞白血病成年幸存者的运动能力和体力活动
  • 批准号:
    8220778
  • 财政年份:
    2009
  • 资助金额:
    $ 53.52万
  • 项目类别:
Motor Proficiency and Physical Activity in Adult Survivors of Childhood ALL
儿童期急性淋巴细胞白血病成年幸存者的运动能力和体力活动
  • 批准号:
    8054848
  • 财政年份:
    2009
  • 资助金额:
    $ 53.52万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 53.52万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了